Greenway Medical Technologies Up 26% on Strong Q1 Earnings
Greenway Medical Technologies (NYSE: GWAY) is is trading higher on the session following its Q1 earnings announcement. The company reported an EPS of $0.08 vs $0.04 estimates and revenue $32.9 million vs $28.54 million estimates.
Tee Green, Greenway president and chief executive officer stated: “We are very pleased with our third-quarter results. We believe these results demonstrate the significant momentum in the business, illustrate the leverage in our model and show the tangible results that revenue mix and our margin-improvement initiatives have on gross margins. Our strategies for growth and innovation are expected to continue driving sustainable revenue, earnings and cash flow growth for 2012 and beyond.”
Greenway is currently trading at $15.57, a gain of $3.25 or 26.38%.
© 2017 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.